Estrogen for quality of life in men with advanced prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether estrogen patches can improve quality of life for men with prostate cancer that has spread but still responds to hormones. It compares adding estrogen to standard hormone therapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of prostate cancer that has spread (metastatic) and still responds to hormone therapy
- You cannot have had chemotherapy for this type of prostate cancer before
- You cannot have already taken certain hormone therapies like Lupron, Zytiga, or Xtandi (bicalutamide is okay)
- You should not have a history of blood clots, heart attack, or stroke in the last 5 years
- Your blood counts and organ function need to be within a safe range (checked by blood tests)
- You must be willing to use effective birth control if sexually active
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding high doses of testosterone to standard chemotherapy (etoposide and carboplatin) can make the chemo work better in men whose prostate cancer has stopped responding to other treatments. It aims to see if this approach can shrink tumors or slow cancer growth.
This trial is for men with metastatic prostate cancer that has already spread beyond the pelvis. It tests whether adding a chemotherapy drug (docetaxel) to the usual hormone therapy plus apalutamide can help control the cancer better than hormone therapy alone.
This Phase 3 trial studies whether using the usual medicines for metastatic prostate cancer, plus a definitive local treatment to the prostate, improves outcomes. It may help determine if treating the prostate directly can benefit people whose cancer has not worsened after initial hormone-based treatment.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This trial tests if wearing an estradiol patch and doing regular exercise can help lessen the side effects of standard hormone therapy (leuprorelin) given with radiation for prostate cancer.
This trial tests if testosterone supplements can improve quality of life for men with low testosterone who are no longer receiving active cancer treatment. It aims to help with symptoms like fatigue and low mood.
Hear when a new Stage IVB Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.